logo

For the Inventor, By the Inventor

Novato, CA, United States of America

Zhi Chen

This inventor holds 6 USPTO granted patents. Top assignee: Biomarin Pharmaceutical Inc.. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhi Chen. Retrieved from https://idiyas.com/inventor/zhi-chen-vzb4k7as

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:

goldMedal6 out of 137 
 
Biomarin Pharmaceutical Inc.
 patents

Years Active: 2013-2025

Loading Chart...
6 patents (USPTO):Explore Patents
1. 12188058 - Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof (2025-01-07),
2. 10934534 - Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof (2021-03-02),
3. 10563183 - Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof (2020-02-18),
4. 9873867 - Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof (2018-01-23),
5. 9200264 - Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof (2015-12-01),
6. 8420368 - Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof (2013-04-16),

Title: Zhi Chen: Innovator in Lysosomal Enzyme Research

Introduction

Zhi Chen is a prominent inventor based in Novato, CA, known for his significant contributions to the field of biochemistry and pharmaceuticals. He holds a total of 6 patents, showcasing his innovative work in the manufacture and application of lysosomal sulfatase enzymes.

Latest Patents

One of Zhi Chen's latest patents focuses on the manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and their uses. This invention provides compositions of active highly phosphorylated lysosomal sulfatase enzymes, along with their pharmaceutical compositions. It also details methods for producing and purifying these enzymes, which are crucial for diagnosing, preventing, and treating diseases associated with lysosomal storage disorders caused by deficiencies in the lysosomal sulfatase enzyme.

Career Highlights

Zhi Chen is currently associated with BioMarin Pharmaceutical Inc., where he continues to advance research in enzyme therapies. His work has been instrumental in developing treatments for lysosomal storage diseases, significantly impacting patient care and therapeutic options.

Collaborations

Zhi Chen collaborates with notable colleagues, including Erno Pungor and Charles Hague, who contribute to his research endeavors and innovations in the field.

Conclusion

Zhi Chen's work exemplifies the intersection of innovation and healthcare, particularly in the development of therapies for lysosomal storage diseases. His contributions continue to pave the way for advancements in enzyme-based treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…